• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmocokinetics of hexobarbital in man after intravenous infusion.

作者信息

Breimer D D, Honhoff C, Zilly W, Richter E, van Rossum J M

出版信息

J Pharmacokinet Biopharm. 1975 Feb;3(1):1-11. doi: 10.1007/BF01066591.

DOI:10.1007/BF01066591
PMID:1127574
Abstract

The plasma levels of hexobarbital in humans were determined during and after a 30-min or 60-min zero-order intravenous infusion. Hexobarbital kinetics could be described by conceiving the body to exhibit two compartments. The plasma concentrations were fitted to the postinfusion equation and the parameters intrinsic to the two-compartment open model were estimated. The elimination half-life varied considerably among the 14 individuals (160-441-min), which could mainly be explained by the greatly varying metabolic clearance of the compound (123-360 ml/min). The apparent volume of distribution per kilogram of body weight was relatively constant (1.10 plus or minus 0.12 liters/kg).

摘要

相似文献

1
Pharmocokinetics of hexobarbital in man after intravenous infusion.
J Pharmacokinet Biopharm. 1975 Feb;3(1):1-11. doi: 10.1007/BF01066591.
2
Pharmacokinetics of hexobarbital in acute hepatitis and after apparent recovery.己巴比妥在急性肝炎及表面恢复后的药代动力学
Clin Pharmacol Ther. 1975 Oct;18(4):433-40. doi: 10.1002/cpt1975184433.
3
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.利福平治疗后通过增加己巴比妥和甲苯磺丁脲清除率来测定人体药物代谢的诱导情况。
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):219-27. doi: 10.1007/BF00614021.
4
Apparent failure of the two-compartment open model in describing the pharmacokinetics of intravenously injected hexobarbital in mice.二室开放模型在描述静脉注射己巴比妥小鼠药代动力学方面的明显失败。
Arch Int Pharmacodyn Ther. 1971 Feb;189(2):388-9.
5
Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.利福平对药物代谢的影响:己巴比妥与安替比林之间的差异。
Clin Pharmacol Ther. 1977 Apr;21(4):470-81. doi: 10.1002/cpt1977214470.
6
Metabolic and psychophysiologic studies of cannabidiol-hexobarbital interaction.
Clin Pharmacol Ther. 1980 Jul;28(1):115-20. doi: 10.1038/clpt.1980.139.
7
Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the rat.肝门静脉输注速率对大鼠己巴比妥药代动力学的影响。
Pharmacology. 1988;36(3):210-6. doi: 10.1159/000138386.
8
Letter: Pharmacokinetics of (+)-, (-)- and (plus or minus)-hexobarbitone in man after oral administration.信函:口服给药后(+)-、(-)-和(±)-己巴比妥在人体中的药代动力学
J Pharm Pharmacol. 1973 Sep;25(9):762-4. doi: 10.1111/j.2042-7158.1973.tb10066.x.
9
Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.人肝内和肝外胆汁淤积时己巴比妥的处置及药物代谢诱导剂的影响。
Eur J Clin Pharmacol. 1980;17(3):197-202. doi: 10.1007/BF00561900.
10
Kinetics of high-dose intravenous morphine in cardiac surgery patients.
Clin Pharmacol Ther. 1976 Jun;19(6):752-6. doi: 10.1002/cpt1976196752.

引用本文的文献

1
An assessment of short-acting hypnotics.短效催眠药的评估。
Drug Saf. 1995 Oct;13(4):257-70. doi: 10.2165/00002018-199513040-00005.
2
Compartment- and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion.
J Pharmacokinet Biopharm. 1980 Jun;8(3):311-8. doi: 10.1007/BF01059648.
3
Disposition of hexobarbital in intra- and extrahepatic cholestasis in man and the influence of drug metabolism-inducing agents.人肝内和肝外胆汁淤积时己巴比妥的处置及药物代谢诱导剂的影响。

本文引用的文献

1
Physiological disposition and chemical fate of thiobarbiturates in the body.
Fed Proc. 1952 Jun;11(2):632-9.
2
[DIFFERENCES IN MICROSOMAL OXIDATION AND ACETYLATION OF DRUGS IN DIFFERENT SPECIES AND RACES].[不同物种和种族中药物的微粒体氧化及乙酰化差异]
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1964 Jul 28;247:509-21. doi: 10.1007/BF00329898.
3
Ultra-short-acting barbiturates as oral hypnotic agents in man.超短效巴比妥类药物作为人类口服催眠剂。
Clin Pharmacol Ther. 1966 May-Jun;7(3):373-8. doi: 10.1002/cpt196673373.
Eur J Clin Pharmacol. 1980;17(3):197-202. doi: 10.1007/BF00561900.
4
Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration.
J Pharmacokinet Biopharm. 1981 Dec;9(6):711-23. doi: 10.1007/BF01070902.
5
The clinical pharmacokinetics of buflomedil in normal subjects after intravenous and oral administration.丁咯地尔在正常受试者静脉注射和口服给药后的临床药代动力学。
Eur J Clin Pharmacol. 1981;20(6):459-63. doi: 10.1007/BF00542100.
6
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults.
Eur J Clin Pharmacol. 1982;22(4):359-65. doi: 10.1007/BF00548406.
7
Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration.
Br J Clin Pharmacol. 1983 Apr;15(4):459-64. doi: 10.1111/j.1365-2125.1983.tb01530.x.
8
Mean residence time in peripheral tissue: a linear disposition parameter useful for evaluating a drug's tissue distribution.外周组织中的平均驻留时间:一个用于评估药物组织分布的线性处置参数。
J Pharmacokinet Biopharm. 1984 Oct;12(5):535-43. doi: 10.1007/BF01060131.
9
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.根据大鼠药代动力学参数预测九种弱酸性和六种弱碱性药物在人体内的处置情况。
J Pharmacokinet Biopharm. 1985 Oct;13(5):477-92. doi: 10.1007/BF01059331.
10
Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital.
Eur J Clin Pharmacol. 1987;32(3):273-7. doi: 10.1007/BF00607575.
4
Studies on the absorption rate of barbiturates in man.巴比妥酸盐在人体中的吸收率研究。
Acta Med Scand. 1965 Nov;178(5):553-9. doi: 10.1111/j.0954-6820.1965.tb04303.x.
5
Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.将人体视为具有单室性质进行药代动力学分析时存在的缺点。
J Pharm Sci. 1968 Jan;57(1):117-23. doi: 10.1002/jps.2600570123.
6
Assessment of pharmacokinetic constants from postinfusion blood curves obtained after I.V. infusion.通过静脉输注后获得的输注后血药浓度曲线评估药代动力学常数。
J Pharm Sci. 1970 Jan;59(1):53-5. doi: 10.1002/jps.2600590107.
7
Rapid and sensitive gas chromatographic determination of hexobarbital in plasma of man using a nitrogen detector.
J Chromatogr. 1974 Jan 30;88(2):235-43. doi: 10.1016/s0021-9673(00)83147-7.
8
[Hexobarbital plasma levels in patients with acute hepatitis during a continuous infusion of hexbarbital].[持续输注己巴比妥期间急性肝炎患者的血浆己巴比妥水平]
Klin Wochenschr. 1973 Apr 1;51(7):346-7. doi: 10.1007/BF01468101.
9
[Barbiturate tolerance in patients with acute hepatitis].[急性肝炎患者的巴比妥类药物耐受性]
Dtsch Med Wochenschr. 1972 Feb 18;97(7):254-5.
10
Letter: Pharmacokinetics of (+)-, (-)- and (plus or minus)-hexobarbitone in man after oral administration.信函:口服给药后(+)-、(-)-和(±)-己巴比妥在人体中的药代动力学
J Pharm Pharmacol. 1973 Sep;25(9):762-4. doi: 10.1111/j.2042-7158.1973.tb10066.x.